Have never been present at FDA meet, know nothing about it. Wouldn't most of it be based on written submissions? Plenty in writing about B. And if not, plenty of p[eople who can address B MOA other than DeG. of course not Leo.
Again, we will see if DeG goes to FDA meet sooner rather than later one hopes-
I think he is much more qualified to discuss the invention of B rather than its clinical trial history
Biomimetics more so than epidemiology better for him